AI Verdict
IMMX has stronger fundamentals based on our AI analysis.
IMNM vs IMMX Fundamental Comparison
| Metric | IMNM | IMMX |
|---|---|---|
| Revenue | $6.9M | $20.0M |
| Net Income | $-212.4M | $-29.4M |
| Net Margin | -3,060.0% | -147.2% |
| ROE | -33.5% | -31.4% |
| ROA | -31.1% | -28.1% |
| Current Ratio | 14.69x | 10.01x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-2.43 | $-0.89 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMNM vs IMMX: Frequently Asked Questions
Is IMNM or IMMX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMMX has stronger fundamentals. IMNM is rated STRONG SELL (88% confidence) while IMMX is rated SELL (75% confidence). This is not investment advice.
How does IMNM compare to IMMX fundamentally?
Immunome Inc. has ROE of -33.5% vs Immix Biopharma, Inc.'s -31.4%. Net margins are -3,060.0% vs -147.2% respectively.
Which stock pays higher dividends, IMNM or IMMX?
IMNM has a dividend yield of N/A or no dividend while IMMX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMNM or IMMX for long term?
For long-term investing, consider that IMNM has STRONG SELL rating with 88% confidence, while IMMX has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMNM vs IMMX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMNM vs IMMX, the AI consensus favors IMMX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.